Biotech Values

[willyw]

ABT-530/493 results-past DAA failures- EASL Program

Since this pertains to treatment failures I am also posting it in this forum (since it could also pertain to re-treating Gilead (sovaldi), JNJ (simeprevir), and BMY (daclatasvir) treatments.

http://www.natap.org/2016/EASL/EASL_13.htm
HIGH EFFICACY OF ABT-493 AND ABT-530 IN HCV GENOTYPE 1-INFECTED PATIENTS WHO HAVE FAILED DIRECT-ACTING ANTIVIRAL-CONTAINING REGIMENS: THE MAGELLAN-I STUDY

A bit greater detail here than most releases.

For those interested, there are also other EASL releases at Natap, and I would anticipate there will be for the Saturday program as well in the near future. ~W